Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF
  • Original article
  • Open access
  • Published:

Adiponectin and its polymorphism: relation to coronary artery disease

The Egyptian Journal of Internal Medicine volume 31, pages 376–381 (2019)Cite this article

En

Abstract

Background

Adiponectin is an adipocytokine with important role in atherosclerosis. Increasing interest has been directed toward the role of adiponectin gene polymorphism in the human genome and its implication in the pathogenesis of coronary artery disease (CAD).

Objectives

The present study investigates the association between the single nucleotide polymorphism +276 G/T of the adiponectin gene and serum adiponectin level in patients with CAD.

Methods

In this study, 100 Egyptian patients with CAD of both sexes and 100 age-matched and sex-matched control volunteers were investigated. All patients were genotyped for +276 G/T polymorphism of adiponectin gene. Lipid profile, fasting blood glucose, and hemoglobin A1c were measured. Adiponectin and high-sensitivity C-reactive protein (hsCRP) levels were determined by ELISA technique. PCR based on restriction fragment length polymorphism was used to determine the genotypes of the studied population.

Results

The lowest serum adiponectin value was observed in patients with CAD compared with control group. The T allele of single nucleotide polymorphisms (SNPs) +276 G/T in the adiponectin gene was found to be associated with CAD (odd ratio 2.23; 95% confidence interval: 1.44–3.45; P=0.001). The significant association of the T allele (GT+TT) of this SNP with lower adiponectin level and hsCRP levels was confirmed in the study (P=0.003 and 0.006, respectively).

Conclusions

Our results concluded that +276 G/T SNP in the adiponectin gene is associated with CAD. Furthermore, carriers of the at-risk T allele had lower serum adiponectin level and higher serum hsCRP, causingin turn an increased risk to develop CAD.

References

  1. Matsuzawa Y. White adipose tissue and cardiovascular disease. Best Pract Res Clin Endocrinol Metab 2005; 19: 637–647.

    CAS  PubMed  Google Scholar 

  2. Lisowska A, Tycinska A, Knapp M, Sawicki R, Lisowski P, Musiał WJ et al. Adiponectin − an independent marker of coronary artery disease occurrence rather than a degree of its advancement in comparison to the IMT values in peripheral arteries. Clin Chim Acta 2012; 413: 749–752.

    CAS  PubMed  Google Scholar 

  3. Scherer PE. The multifaceted roles of adipose tissue-therapeutic targets for diabetes and beyond: the 2015 Banting Lecture. Diabetes 2016; 65: 1452–1461.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Shibata R, Ouchi N, Murohara T. Adiponectin and cardiovascular disease. Circ J 2009; 73: 608–614.

    CAS  PubMed  Google Scholar 

  5. Salmenniemi U, Zacharova J, Ruotsalainen E, Vauhkonen I, Pihlajamäki J, Kainulainen S et al. Association of adiponectin level and variants in the adiponectin gene with glucose metabolism, energy expenditure, and cytokines in offspring of type 2 diabetic patients. J Clin Endocrinol Metab 2006; 90: 4216–4223.

    Google Scholar 

  6. Wu Y, Li Y, Lange EM, Croteau-Chonka DC, Kuzawa CW, McDade TW et al. Genome-wide association study for adiponectin levels in Filipino women identifies CDH13 and a novel uncommon haplotype at KNG1-ADIPOQ. Hum Mol Genet 2010; 19: 4955–4964.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, Scott RA et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet 2012; 8: e1002607.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Qi L, Menzaghi C, Salvemini L, De Bonis C, Trischitta V, Hu FB. Novel locus FER is associated with serum HMW adiponectin levels. Diabetes 2011; 60: 2197–2201.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: 85–89.

    CAS  PubMed  Google Scholar 

  10. Giannessi D, Maltinti M, Del Ry S. Adiponectin circulating levels: a new emerging biomarker of cardiovascular risk. Pharmacol Res 2007; 56: 459–467.

    CAS  PubMed  Google Scholar 

  11. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE et al. Hypoadiponectinemia in obesity and type2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930–1935.

    CAS  PubMed  Google Scholar 

  12. Trujillo ME, Scherer PE. Adiponectin − journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 2005; 257: 167–175.

    CAS  PubMed  Google Scholar 

  13. Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta 2007; 380: 24–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Yang WS, Chuang LM. Human genetics of adiponectin in the metabolic syndrome. J Mol Med (Berl) 2006; 84: 112–121.

    CAS  Google Scholar 

  15. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002; 51: 536–540.

    CAS  PubMed  Google Scholar 

  16. Dai X, Wiernek S, Evans JP, Runge MS. Genetics of coronary artery disease and myocardial infarction. World J Cardiol 2016; 8: 1–23.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Borges MC, Lawlor DA, de Oliveira C, White J, Horta BL, Barros AJ. Role of adiponectin in coronary heart disease risk: a Mendelian randomization study. Circ Res 2016; 119: 491–499.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Menzaghi C, Trischitta V. The adiponectin paradox for all-cause and cardiovascular mortality. Diabetes 2018; 67: 12–22.

    CAS  PubMed  Google Scholar 

  19. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2017; 40(Suppl 1):S13–S25.

    Google Scholar 

  20. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507–520.

    CAS  PubMed  Google Scholar 

  21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.

    CAS  PubMed  Google Scholar 

  22. Aritaa Y, Kiharaa S, Ouchia N, Takahashia M, Maedaa K, Miyagawaa J et al. Paradoxical decrease of an adipose specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 267: 79–83.

    Google Scholar 

  23. Ridker PM. C-reactive protein and risks of future myocardial infarction and thrombotic stroke. Eur Heart J 1998; 19: 1–3.

    CAS  PubMed  Google Scholar 

  24. Musso G, Gambino R, De Michieli F, Durazzo M, Pagano G, Cassader M. Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH. Hepatology 2008; 47: 1167–1177.

    CAS  PubMed  Google Scholar 

  25. WHO (24 May 2018) The top 10 causes of death www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death

  26. Gong M, Long J, Liu Q, Deng HC. Association of the ADIPOQ rs17360539 and rs266729 polymorphisms with type 2 diabetes: a meta-analysis. Mol Cell Endocrinol 2010; 325: 78–83.

    CAS  PubMed  Google Scholar 

  27. Dallinga-Thie GM, Dullaart RP. Do genome-wide association scans provide additional information on the variation of plasma adiponectin concentrations? Atherosclerosis 2010; 208: 328–329.

    CAS  PubMed  Google Scholar 

  28. Filippi E, Sentinelli F, Romeo S, Arca M, Berni A, Tiberti C et al. The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age<=50 years). J Mol Med (Berl) 2005; 83: 711–719.

    CAS  Google Scholar 

  29. Mackawy A, Alzohairy M, Ahmed E, Badawy M. Adiponectin gene polymorphism and the incidence of type 2 diabetes mellitus in obese patients in Qassim region, Saudi Arabia. J Am Sci 2011; 7: 191–203.

    Google Scholar 

  30. Iacobellis G, Petrone A, Leonetti F, Buzzetti R. Left ventricular mass and +276 G/G single nucleotide polymorphism of the adiponectin gene in uncomplicated obesity. Obesity (Silver Spring) 2006; 14: 368–372.

    CAS  Google Scholar 

  31. Leu HB, Chung CM, Lin SJ, Jong YS, Pan WH, Chen JW. Adiponectin Gene Polymorphism is selectively associated with the concomitant presence of metabolic syndrome and essential hypertension. PLoS One 2011; 6: 19999.

    Google Scholar 

  32. Szmitko PE, Teoh H, Stewart DJ, Verma S. Adiponectin and cardiovascular disease: state of the art? Am J Physiol Heart Circ Physiol 2007; 292: 1655–1663.

    Google Scholar 

  33. Melanie C, Amelie C, Anee Q, Benoit J, Isabelle L, Jean P et al. Adiponectin and Risk of Coronary Heart Disease in Apparently Healthy Men and Women (from the EPIC-Norfolk Prospective Population Study). Am J Cardiol 2011; 108: 367–373.

    Google Scholar 

  34. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291: 1730–1737.

    CAS  PubMed  Google Scholar 

  35. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002; 106: 2767–2770.

    CAS  PubMed  Google Scholar 

  36. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002; 105: 2893–2898.

    CAS  PubMed  Google Scholar 

  37. Fernández-Real JM, Castro A, Vázquez G, Casamitjana R, López-Bermejo A, Peñarroja G et al. Adiponectin is associated with vascular function independent of insulin sensitivity. Diabetes Care 2004; 27: 739–745.

    PubMed  Google Scholar 

  38. Yang WS, Tsou PL, Lee WJ, Tseng DL, Chen CL, Peng CC et al. Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. J Mol Med (Berl) 2003; 81: 428–434.

    CAS  Google Scholar 

  39. Heid IM, Henneman P, Hicks A, Coassin S, Winkler T, Aulchenko YS et al. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 2010; 208: 412–420.

    CAS  PubMed  Google Scholar 

  40. Boumaiza I, Omezzine A, Rejeb J, Rebhi L, Ben Rejeb N, Nabli N et al. Single-nucleotide polymorphisms at the adiponectin locus and risk of coronary artery disease in Tunisian coronaries. J Cardiovasc Med (Hagerstown) 2011; 12: 619–624.

    Google Scholar 

  41. Zhang BC, Li WM, Xu YW. A meta-analysis of the association of adiponectin gene polymorphisms with coronary heart disease in Chinese Han population. Clin Endocrinol (Oxf) 2012 76:358–364.

    CAS  Google Scholar 

  42. Mansourian M, Javanmard SH. Adiponectin gene polymorphisms and susceptibility to atherosclerosis: a meta-analysis. J Res Med Sci 2013; 18: 611–616.

    PubMed  PubMed Central  Google Scholar 

  43. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002; 106: 913–919.

    CAS  PubMed  Google Scholar 

  44. Shreshtha S, Sharma P, Kumar P, Sharma R, Gupta S, Mahapatra T. Study of serum adiponectin and high sensitivity C-reactive protein in diabetic patients. Asian J Pharm Clin Res 2018; 11: 163–166.

    Google Scholar 

  45. Brito V, Alcaraz A, Augustovski F, Pichón-Riviere A, García-Martí S, Bardach A et al.; Grupo de Evaluación de Tecnologías Sanitarias. High sensitivity C protein as an independent risk factor in people with and without history of cardiovascular disease. Arch Cardiol Mex 2015; 85:124–135.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine Diabetes and Endocrinology, Faculty of Medicine, Cairo University, Giza, Egypt

    Nashwa S. Ghanem MD & Naglaa M. El-Sayed

  2. Department of Critical Care Medicine, Faculty of Medicine, Cairo University, Giza, Egypt

    Ahmed K. Abbas

  3. Department of Medical Biochemistry, Faculty of Medicine, Cairo University, Giza, Egypt

    Ollfat G. Shaker

Authors
  1. Nashwa S. Ghanem MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naglaa M. El-Sayed
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ahmed K. Abbas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ollfat G. Shaker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nashwa S. Ghanem MD.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ghanem, N.S., El-Sayed, N.M., Abbas, A.K. et al. Adiponectin and its polymorphism: relation to coronary artery disease. Egypt J Intern Med 31, 376–381 (2019). https://doi.org/10.4103/ejim.ejim_11_19

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_11_19

Keywords